hrp0089p3-p055 | Bone, Growth Plate & Mineral Metabolism P3 | ESPE2018
, James Beki
, Feltbower Richard
, Mushtaq Talat
, Kinsey Sally
Introduction: Osteonecrosis can be a debilitating consequence of treatment for acute lymphoblastic leukaemia (ALL), most commonly affecting patients aged between 10 and 20 years at diagnosis of malignancy. Patients may have asymptomatic lesions that spontaneously regress, and little is known about the natural history of lesions. There is also limited understanding of the relationship between osteonecrosis and other markers of bone health.Aims: The aims o...